[1
]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA;
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department
of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Medical
Oncology, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer,
Barcelona 08036, Spain.
[2
]
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute,
Boston, MA 02215, USA; Department of Biostatistics, Harvard School of Public Health,
Boston, MA 02115, USA.
[3
]
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute,
Boston, MA 02215, USA; Department of Biostatistics, Harvard School of Public Health,
Boston, MA 02115, USA; Center for Applied Scientific Computing, Lawrence Livermore
National Laboratory, Livermore, CA 94550, USA.
[4
]
Departments of Physics and Biology and Koch Institute for Integrative Cancer Research,
Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Molecular
Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
[5
]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA;
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department
of Medicine, Harvard Medical School, Boston, MA 02115, USA.
[6
]
Department of Medical Oncology, Hospital Clinic, Institut d'Investigacions Biomediques
August Pi i Sunyer, Barcelona 08036, Spain.
[7
]
Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet,
Oslo 0424, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical
Medicine, Faculty of Medicine, University of Oslo, Oslo 0316, Norway; Department of
Pathology, Oslo University Hospital, Oslo 0424, Norway.
[8
]
Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet,
Oslo 0424, Norway; Department of Oncology, Oslo University Hospital, Oslo 0424, Norway;
Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0316,
Norway.
[9
]
Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet,
Oslo 0424, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical
Medicine, Faculty of Medicine, University of Oslo, Oslo 0316, Norway.
[10
]
Departments of Physics and Biology and Koch Institute for Integrative Cancer Research,
Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Hubrecht Institute,
Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht,
Uppsalalaan 8, 3584 CT, Utrecht, the Netherlands.
[11
]
The Royal Marsden Hospital, The Breakthrough Breast Cancer Research Centre, Institute
of Cancer Research, London SW3 6JJ, UK.
[12
]
The Royal Marsden Hospital, The Breakthrough Breast Cancer Research Centre, Institute
of Cancer Research, London SW3 6JJ, UK; Seattle Cancer Care Alliance, Seattle, WA
98109-1023, USA.
[13
]
The Royal Marsden Hospital, The Breakthrough Breast Cancer Research Centre, Institute
of Cancer Research, London SW3 6JJ, UK; Department of Pathology, Memorial Sloan-Kettering
Cancer Center, New York, NY 10065, USA.
[14
]
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center,
New York, NY 10065, USA.
[15
]
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute,
Boston, MA 02215, USA; Department of Biostatistics, Harvard School of Public Health,
Boston, MA 02115, USA. Electronic address: michor@jimmy.harvard.edu.
[16
]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA;
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department
of Medicine, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute,
Cambridge, MA 02138, USA; Broad Institute, Cambridge, MA 02142, USA. Electronic address:
kornelia_polyak@dfci.harvard.edu.
